171 related articles for article (PubMed ID: 37402831)
21. Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
Miceli R; An J; Di Bartolomeo M; Morano F; Kim ST; Park SH; Choi MG; Lee JH; Raimondi A; Fucà G; Sohn TS; Bae JM; Kim S; Lim DH; Kang WK; Kim KM; Pietrantonio F; Lee J
Oncology; 2019; 97(1):38-43. PubMed ID: 31048579
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259
[TBL] [Abstract][Full Text] [Related]
24. Chemosensitivity and survival in gastric cancer patients with microsatellite instability.
Oki E; Kakeji Y; Zhao Y; Yoshida R; Ando K; Masuda T; Ohgaki K; Morita M; Maehara Y
Ann Surg Oncol; 2009 Sep; 16(9):2510-5. PubMed ID: 19565284
[TBL] [Abstract][Full Text] [Related]
25. Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.
Vos EL; Maron SB; Krell RW; Nakauchi M; Fiasconaro M; Capanu M; Walch HS; Chatila WK; Schultz N; Ilson DH; Janjigian YY; Ku GY; Yoon SS; Coit DG; Vanderbilt CM; Tang LH; Strong VE
Ann Surg; 2023 May; 277(5):798-805. PubMed ID: 35766391
[TBL] [Abstract][Full Text] [Related]
26. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy.
Jiang D; Shu C; Zhang W; Sun L; Zhang M; He Y; Owen G; Jin W; He D; Deng X; Liu X
Virchows Arch; 2021 Feb; 478(2):231-240. PubMed ID: 32588133
[TBL] [Abstract][Full Text] [Related]
27. Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
Polom K; Böger C; Smyth E; Marrelli D; Behrens HM; Marano L; Becker T; Lordick F; Röcken C; Roviello F
Eur J Surg Oncol; 2018 May; 44(5):626-631. PubMed ID: 29545085
[TBL] [Abstract][Full Text] [Related]
28. Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.
Tsai CY; Lin TA; Huang SC; Hsu JT; Yeh CN; Chen TC; Chiu CT; Chen JS; Yeh TS
Oncologist; 2020 Jul; 25(7):e1021-e1030. PubMed ID: 32058649
[TBL] [Abstract][Full Text] [Related]
29. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B
Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194
[TBL] [Abstract][Full Text] [Related]
30. Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer.
Oh SY; Kim DY; Kim YB; Suh KW
World J Surg; 2013 Oct; 37(10):2497-503. PubMed ID: 23754140
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts.
Quaas A; Biesma HD; Wagner AD; Verheij M; van Berge Henegouwen MI; Schoemig-Markiefka B; Pamuk A; Zander T; Siemanowski J; Sikorska K; Egthuijsen JMP; Meershoek-Klein Kranenbarg EM; van de Velde CJH; Buettner R; Alakus H; Cats A; Ylstra B; van Laarhoven HWM; van Grieken NCT
Eur J Cancer; 2022 Sep; 173():95-104. PubMed ID: 35863110
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine.
Kang BW; Kim JG; Lee SJ; Chae YS; Moon JH; Sohn SK; Jeon SW; Jung MK; Lim KH; Jang YS; Park JS; Jun SH; Choi GS
Med Oncol; 2011 Dec; 28 Suppl 1():S214-8. PubMed ID: 20953739
[TBL] [Abstract][Full Text] [Related]
33. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma.
Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K
Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
Kim GP; Colangelo LH; Wieand HS; Paik S; Kirsch IR; Wolmark N; Allegra CJ;
J Clin Oncol; 2007 Mar; 25(7):767-72. PubMed ID: 17228023
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
37. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery.
Fang WL; Chang SC; Lan YT; Huang KH; Chen JH; Lo SS; Hsieh MC; Li AF; Wu CW; Chiou SH
World J Surg; 2012 Sep; 36(9):2131-8. PubMed ID: 22669398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]